A letter published in The New England Journal of Medicine provides narrative of a clinical interference that has been documented with the much hailed multiple myeloma drug daratumumab. A letter ...
The US Food and Drug Administration (FDA) has approved a new molecular assay, ID CORE XT (Progenika Biopharma), for use in transfusion medicine to help determine blood compatibility between donor and ...
If blood with poorly matched antibodies is transfused, the procedure is more likely to lead to red blood cell destruction and a transfusion reaction, the agency explained. HealthDay News — The US Food ...
Health board adopts new Laboratory Information Management System (LIMS) to support transfusion laboratory testing and blood ...
FRIDAY, Oct. 12, 2018 -- The U.S. Food and Drug Administration has approved the ID CORE XT DNA-based test to help doctors verify blood compatibility before a transfusion. People who need repeated ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results